Phio Pharmaceuticals (PHIO) Prepaid Assets (2011 - 2026)
Phio Pharmaceuticals' (PHIO) quarterly Prepaid Assets came in at $371000.0 in Q1 2026, up 134.81% YoY from $158000.0 in Q1 2025, and down 16.63% on a QoQ basis from $445000.0 in Q4 2025.
Phio Pharmaceuticals (PHIO) Prepaid Assets (2011 - 2026) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 16 years of Prepaid Assets data on file, last reported at $371000.0 in Q1 2026.
- Quarterly Prepaid Assets rose 134.81% year-over-year to $371000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $371000.0 (up 134.81% YoY) and the FY2025 annual result came in at $445000.0, up 25.71% from the prior year.
- Prepaid Assets declined to $371000.0 in Q1 2026, from $445000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.6 million in Q2 2022 to a low of $158000.0 in Q1 2025.
- A 5-year average of $647647.1 and a median of $594000.0 in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets plunged 72.45% — and 2026, when it jumped 134.81%.
- Tracing PHIO's Prepaid Assets over 5 years: stood at $615000.0 in 2022, then surged by 35.28% to $832000.0 in 2023, then sank by 57.45% to $354000.0 in 2024, then gained by 25.71% to $445000.0 in 2025, then dropped by 16.63% to $371000.0 in 2026.
- The last three Prepaid Assets figures came in at $371000.0 (Q1 2026), $445000.0 (Q4 2025), and $788000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Phio Pharmaceuticals | 13.77 Mn | 13.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.30 Mn |
| Mar 31, 2026 | 371,000.00 |
| Dec 31, 2025 | 445,000.00 |
| Sep 30, 2025 | 788,000.00 |
| Jun 30, 2025 | 519,000.00 |
| Mar 31, 2025 | 158,000.00 |
| Dec 31, 2024 | 354,000.00 |
| Sep 30, 2024 | 474,000.00 |
| Jun 30, 2024 | 594,000.00 |
| Mar 31, 2024 | 373,000.00 |
| Dec 31, 2023 | 832,000.00 |
| Sep 30, 2023 | 871,000.00 |
| Jun 30, 2023 | 678,000.00 |
| Mar 31, 2023 | 319,000.00 |
| Dec 31, 2022 | 615,000.00 |
| Sep 30, 2022 | 843,000.00 |
| Jun 30, 2022 | 1.62 Mn |
| Mar 31, 2022 | 1.16 Mn |
| Dec 31, 2021 | 620,000.00 |
| Sep 30, 2021 | 871,000.00 |